Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?. (November 2020)
- Record Type:
- Journal Article
- Title:
- Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?. (November 2020)
- Main Title:
- Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
- Authors:
- Tang, Hai
Ren, Yijiu
She, Yunlang
Dai, Chenyang
Wang, Tingting
Su, Hang
Sun, Weiyan
Jiang, Gening
Chen, Chang - Abstract:
- Aims: Interstitial lung disease (ILD) is associated with the incidence of non-small cell lung cancer (NSCLC). Patients with ILD are at risk of acute exacerbation (AE) after pulmonary resection. However, there have been no recognized treatment guidelines for NSCLC patients with ILD on computed tomography (CT). Methods: We reviewed the medical records of 156 consecutive patients with ILD on high-resolution CT who have undergone pulmonary resection and between 2014 and 2018. Data regarding general information, imaging features, perioperative indicators, and long-term prognosis of patients were compared. Results: The mean patient age was 67.24 ± 6.80 years. Postoperative AE occurred in seven (4.5%) patients; five (71.4%) of the seven patients who had an AE died within 30 days. The incidence of postoperative AE was 5.3% among patients who underwent lobectomy ( n = 6). Overall survivals (OS) was significantly poorer in patients with possible usual interstitial pneumonia (UIP)/UIP [hazard ratio (HR) 2.34, 95% confidence interval (CI) 1.11–4.95, p = 0.026] and severe postoperative complications (Grade ⩾3) ( versus no complication: HR 2.58, 95% CI 1.11–6.02, p = 0.028; versus mild complications: HR 6.05, 95% CI 2.69–13.6, p < 0.001). Age (HR 1.071, 95% CI 1.006–1.137, p = 0.030) and ILD patterns (HR 2.420, 95% CI 1.024–5.716, p = 0.044) were independent prognostic factors for OS. Forced vital capacity (FVC) (odds ratio 0.351, 95% CI 0.145–0.850, p = 0.020) was an independentAims: Interstitial lung disease (ILD) is associated with the incidence of non-small cell lung cancer (NSCLC). Patients with ILD are at risk of acute exacerbation (AE) after pulmonary resection. However, there have been no recognized treatment guidelines for NSCLC patients with ILD on computed tomography (CT). Methods: We reviewed the medical records of 156 consecutive patients with ILD on high-resolution CT who have undergone pulmonary resection and between 2014 and 2018. Data regarding general information, imaging features, perioperative indicators, and long-term prognosis of patients were compared. Results: The mean patient age was 67.24 ± 6.80 years. Postoperative AE occurred in seven (4.5%) patients; five (71.4%) of the seven patients who had an AE died within 30 days. The incidence of postoperative AE was 5.3% among patients who underwent lobectomy ( n = 6). Overall survivals (OS) was significantly poorer in patients with possible usual interstitial pneumonia (UIP)/UIP [hazard ratio (HR) 2.34, 95% confidence interval (CI) 1.11–4.95, p = 0.026] and severe postoperative complications (Grade ⩾3) ( versus no complication: HR 2.58, 95% CI 1.11–6.02, p = 0.028; versus mild complications: HR 6.05, 95% CI 2.69–13.6, p < 0.001). Age (HR 1.071, 95% CI 1.006–1.137, p = 0.030) and ILD patterns (HR 2.420, 95% CI 1.024–5.716, p = 0.044) were independent prognostic factors for OS. Forced vital capacity (FVC) (odds ratio 0.351, 95% CI 0.145–0.850, p = 0.020) was an independent prognostic factor for patients who needed postoperative intensive care unit intervention. Conclusion: Pulmonary resection for NSCLC Patients with ILD on CT is a safe procedure. However, surgical indications for lobectomy need to be more carefully for these patients, especially for possible UIP/UIP patients and patients with lower FVC. The reviews of this paper are available via the supplemental material section. … (more)
- Is Part Of:
- Therapeutic advances in respiratory disease. Volume 14(2020)
- Journal:
- Therapeutic advances in respiratory disease
- Issue:
- Volume 14(2020)
- Issue Display:
- Volume 14, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 14
- Issue:
- 2020
- Issue Sort Value:
- 2020-0014-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11
- Subjects:
- complications -- interstitial lung disease -- lung cancer surgery -- surgery
Respiratory organs -- Diseases -- Periodicals
Respiratory agents -- Periodicals
Pulmonary pharmacology -- Periodicals
Respiratory Tract Diseases -- Periodicals
Respiratory System Agents -- therapeutic use -- Periodicals
Respiratory Tract Diseases -- drug therapy -- Periodicals
Lung Diseases -- drug therapy -- Periodicals
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Agents respiratoires -- Périodiques
Pharmacologie pulmonaire -- Périodiques
616.2005 - Journal URLs:
- http://tar.sagepub.com ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/1753466620971137 ↗
- Languages:
- English
- ISSNs:
- 1753-4658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14755.xml